Otsuka says Samsca generic infringes

15-03-2022

Alex Baldwin

Otsuka says Samsca generic infringes

Morumotto / Shutterstock.com

Otsuka Pharmaceuticals has filed a patent infringement suit against MSN Laboratories targeting the company’s planned generic Samsca (tolvaptan) heart medication.


Otsuka Pharmaceuticals, MSN Laboratories, US District Court for the District of Delaware, Samsca, FDA

LSIPR